e-learning
resources
Milan 2017
Sunday, 10.09.2017
Novel molecular and genetic targets in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Functional investigation of the corticosteroid resistance candidate FKBP5 using a CRISPR-Cas9 knockout model
A. Faiz (Groningen, Netherlands)
Source:
International Congress 2017 – Novel molecular and genetic targets in COPD
Session:
Novel molecular and genetic targets in COPD
Session type:
Poster Discussion
Number:
372
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Faiz (Groningen, Netherlands). Late Breaking Abstract - Functional investigation of the corticosteroid resistance candidate FKBP5 using a CRISPR-Cas9 knockout model. 372
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
FKBP5 a candidate for corticosteroid insensitivity in COPD
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
Late Breaking Abstract - Identification and functional testing of a novel receptor for SP-A on eosinophils
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Late Breaking Abstract - Biological phenotypes of ARDS show differential expression of genes involved in oxidative phosphorylation and immunomodulation: an illustration for the need of personalized medicine in ARDS.
Source: International Congress 2018 – Ventilation and lung imaging in critically ill patients
Year: 2018
Late Breaking Abstract - Evidence of target engagement and pathway modulation: biomarker analysis of the phase 1b inhaled seralutinib study
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Late Breaking Abstract - Contribution of P2X7 1513A/C loss-of-function polymorphism and tuberculosis susceptibility in Egyptian population
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
Identification and characterisation of seven novel SERPINA1 null mutations
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
LSC 2010 Abstract: Functional variant of the
ANXA11
gene: True marker of protection and candidate disease modifier in sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
Late Breaking Abstract: A genome-wide association study identifies variants at 12q13.3-q14.1 as genetic risk factors for sarcoidosis
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
Late Breaking Abstract - Steroid resistance in obese asthmatic patients: a potential role of obesity-related systemic oxidative stress
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
MiR-320d: A novel anti-inflammatory miRNA up regulated by corticosteroids
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
Re-sequencing of
PLAUR
in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Late Breaking Abstract: Cathelicidin has direct anti-rhinoviral activity
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
Evaluation of gene expression during in vitro ciliogenesis to search for novel candidate genes in primary ciliary dyskinesia
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm
Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Year: 2020
Late Breaking Abstract - Transcriptomic signature for precise prediction of systemic drug reaction during 3HP treatment for latent tuberculosis infection
Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection
Year: 2021
Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time.
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept